JD Health International Inc
HKEX:6618

Watchlist Manager
JD Health International Inc Logo
JD Health International Inc
HKEX:6618
Watchlist
Price: 27.3 HKD -4.55% Market Closed
Market Cap: 87.1B HKD
Have any thoughts about
JD Health International Inc?
Write Note

JD Health International Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

JD Health International Inc
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
JD Health International Inc
HKEX:6618
Total Liabilities & Equity
ÂĄ61.3B
CAGR 3-Years
12%
CAGR 5-Years
120%
CAGR 10-Years
N/A
Vipshop Holdings Ltd
NYSE:VIPS
Total Liabilities & Equity
ÂĄ69.5B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
18%
Alibaba Group Holding Ltd
NYSE:BABA
Total Liabilities & Equity
ÂĄ1.8T
CAGR 3-Years
1%
CAGR 5-Years
9%
CAGR 10-Years
22%
Pinduoduo Inc
NASDAQ:PDD
Total Liabilities & Equity
ÂĄ466.8B
CAGR 3-Years
41%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Meituan
HKEX:3690
Total Liabilities & Equity
ÂĄ285.6B
CAGR 3-Years
6%
CAGR 5-Years
18%
CAGR 10-Years
N/A
JD.Com Inc
HKEX:9618
Total Liabilities & Equity
ÂĄ643.6B
CAGR 3-Years
10%
CAGR 5-Years
21%
CAGR 10-Years
26%
No Stocks Found

JD Health International Inc
Glance View

Market Cap
86.8B HKD
Industry
Retail

JD Health International Inc. is not just another player in the rapidly evolving health and wellness landscape; it stands out as a pioneering force driven by technology and innovation. Established in 2015 as a subsidiary of JD.com, one of China's largest e-commerce platforms, JD Health is leveraging its parent company's robust logistics network and cutting-edge technology to reshape healthcare access in China. The company focuses on providing a seamless online healthcare experience, offering a diverse range of services that include online pharmacy sales, health consultations, and prescription management. With growing consumer demand for digital health solutions, JD Health is capitalizing on the shift toward telemedicine and remote healthcare services, positioning itself as a leader in this promising market. For investors, JD Health International Inc. represents a compelling opportunity rooted in strong growth prospects and market leadership. As digital health continues to gain traction, the company has demonstrated impressive revenue growth, propelled by its extensive user base and innovative service offerings. JD Health’s commitment to leveraging advanced technologies like artificial intelligence and big data analytics not only enhances operational efficiency but also improves customer satisfaction and outcomes. Coupled with a solid financial backing from JD.com's established marketplace and logistics capabilities, JD Health is strategically poised to expand its footprint in both urban and rural areas, ultimately aiming to bridge the healthcare accessibility gap in China. As the company navigates the dynamic healthcare environment, its growth trajectory suggests a sustainable business model with substantial long-term value.

Intrinsic Value
34.56 HKD
Undervaluation 21%
Intrinsic Value
Price

See Also

What is JD Health International Inc's Total Liabilities & Equity?
Total Liabilities & Equity
61.3B CNY

Based on the financial report for Dec 31, 2023, JD Health International Inc's Total Liabilities & Equity amounts to 61.3B CNY.

What is JD Health International Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
120%

Over the last year, the Total Liabilities & Equity growth was 0%. The average annual Total Liabilities & Equity growth rates for JD Health International Inc have been 12% over the past three years , 120% over the past five years .

Back to Top